Rare Skin Reactions from Tislelizumab: Cancer and Rash
The expanding frontier of immunotherapy has brought substantial breakthroughs in cancer treatment, harnessing the power of immune checkpoint inhibitors (ICIs)...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
The expanding frontier of immunotherapy has brought substantial breakthroughs in cancer treatment, harnessing the power of immune checkpoint inhibitors (ICIs)...
Researchers at the University of Illinois Chicago (UIC) have unveiled a promising breakthrough in the fight against herpes simplex virus...
In the continuously evolving landscape of oncology, one invisible yet insidious adversary persists alongside cancer itself: chronic stress. Far from...
In a landmark ten-year study presented at the 15th European Breast Cancer Conference (EBCC15) in Barcelona, new evidence highlights the...
In a groundbreaking advancement poised to transform symptomatic treatment for men undergoing androgen deprivation therapy (ADT) for prostate cancer, researchers...
A groundbreaking study published on March 17, 2026, in the esteemed journal Oncotarget unveils the pivotal role of the transcription...
In a groundbreaking advancement poised to reshape cancer therapeutics, researchers at Dartmouth Cancer Center (DCC) have unveiled compelling evidence that...
In a groundbreaking study set to shift paradigms in cancer biology, researchers have illuminated the sophisticated ways through which the...
In a groundbreaking systematic review and meta-analysis published in JAMA Dermatology, researchers have drawn significant conclusions about the efficacy of...
An international coalition of researchers hailing from Baylor College of Medicine, Texas Children’s Hospital, McGill University, and the University of...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine